NewGenIvf Group Limited
NIVF
$1.78
$0.031.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -108.20K | -19.90K | -198.30K | -198.30K | 335.60K |
| Total Depreciation and Amortization | 179.90K | 9.30K | 8.50K | 8.50K | 167.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -175.20K | -10.50K | 4.40K | 4.40K | 29.00K |
| Change in Net Operating Assets | -5.54M | -6.80M | 2.29M | 2.29M | -740.00K |
| Cash from Operations | -5.65M | -6.83M | 2.10M | 2.10M | -208.40K |
| Capital Expenditure | -2.70K | -39.90K | -5.20K | -5.20K | -17.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.40K | -15.30K | -500.00 | -500.00 | -- |
| Cash from Investing | 13.70K | -55.30K | -5.70K | -5.70K | -17.50K |
| Total Debt Issued | 6.17M | -1.02M | 1.97M | 1.97M | 509.80K |
| Total Debt Repaid | 128.30K | -128.30K | -3.20K | -3.20K | 4.70K |
| Issuance of Common Stock | 127.60K | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -537.70K | 8.29M | -4.14M | -4.14M | -164.70K |
| Cash from Financing | 5.89M | 7.14M | -2.18M | -2.18M | 349.80K |
| Foreign Exchange rate Adjustments | 32.10K | -271.80K | 142.30K | 142.30K | -106.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 288.10K | -14.40K | 65.00K | 65.00K | 17.00K |